Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and/or protein expression.

Transfusion
Loann RaudYann Fichou

Abstract

Although D variant phenotype is known to be due to genetic defects, including rare missense single nucleotide variants (SNVs), within the RHD gene, few studies have addressed the molecular and cellular mechanisms driving this altered expression. We and others showed previously that splicing is commonly disrupted by SNVs in constitutive splice sites and their vicinity. We thus sought to investigate whether rare missense SNVs located in "deep" exonic regions could also impair this mechanism. Forty-six missense SNVs reported within exons 6 and 7 were first selected from the Human RhesusBase. Their respective effect on splicing was assessed by using an in vitro assay. An RhD-negative cell model was further generated by using the CRISPR-Cas9 approach. RhD-mutated proteins were overexpressed in the newly created model, and cell membrane expression of the D antigen was measured by flow cytometry. Minigene splicing assay showed that 14 of 46 (30.4%) missense SNVs alter splicing. Very interestingly, further investigation of two missense SNVs, which both affect codon 338 and confer a weak D phenotype, showed various mechanisms: c.1012C>G (p.Leu338Val) disrupts splicing only, while c.1013T>C (p.Leu338Pro) alters only the protein structure...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C Le van KimY Colin
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B Chérif-ZaharY Colin
Aug 10, 2001·BMC Genetics·F F WagnerW A Flegel
Aug 30, 2002·Blood·Franz F WagnerWilly A Flegel
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Jun 16, 2005·Nature Reviews. Molecular Cell Biology·Arianne J MatlinChristopher W J Smith
Nov 12, 2005·British Journal of Haematology·Matthew J ConroyNeil D Avent
Mar 3, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Chao-Peng ShaoYi-Yan Zhou
Apr 6, 2006·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·I CallebautJ-P Cartron
Dec 21, 2006·Transfusion·Timo A LuettringhausWilly A Flegel
Feb 1, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Willy A Flegel
Jun 11, 2011·Genome Research·Shengdong KeLawrence A Chasin
Sep 11, 2012·Journal of Medical Genetics·Pascaline GaildratAlexandra Martins
Dec 30, 2014·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Franz F Wagner, Willy A Flegel
Mar 29, 2016·British Journal of Haematology·Tamara C StegmannC Ellen van der Schoot
Aug 3, 2016·Transfusion·Kshitij SrivastavaWilly Albert Flegel
Nov 2, 2016·FEBS Letters·Yuexin ZhouWensheng Wei
May 17, 2017·British Journal of Haematology·S Gerald SandlerWilly A Flegel
Aug 2, 2017·International Journal of Molecular Sciences·Lucie GrodeckáTomáš Freiberger
Apr 24, 2018·Journal of Applied Genetics·Abramowicz Anna, Gos Monika

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.